GWM
MRNA icon

GSB Wealth Management’s Moderna MRNA Stock Holding History

GSB Wealth Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$769K Buy
15,140
+15
+0.1% +$700 0.17% 116
2025
Q4 		$446K Buy
15,125
+4,850
+47% +$132K 0.1% 149
2025
Q3 		$265K Sell
10,275
-30
-0.3% -$837 0.06% 202
2025
Q2 		$284K Buy
10,305
+1,995
+24% +$52.5K 0.07% 189
2025
Q1 		$236K Sell
8,310
-1,991
-19% -$70.7K 0.06% 196
2024
Q4 		$428K Buy
10,301
+5,009
+95% +$239K 0.11% 147
2024
Q3 		$354K Buy
5,292
+2,000
+61% +$184K 0.09% 166
2024
Q2 		$391K Hold
3,292
– – 0.11% 155
2024
Q1 		$351K Hold
3,292
– – 0.1% 163
2023
Q4 		$327K Buy
+3,292
New +$277K 0.1% 160
2023
Q3 		– Sell
-1,792
Closed -$218K – 201
2023
Q2 		$218K Buy
+1,792
New +$239K 0.07% 195
2021
Q3 		– Sell
-915
Closed -$215K – 192
2021
Q2 		$215K Buy
+915
New +$164K 0.07% 210

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

GSB Wealth Management's MRNA Position: Q1 2026 in Review

GSB Wealth Management increased its Moderna (MRNA) stake by 0.1% in Q1 2026, buying an estimated $700 and bringing the position to 15,140 shares worth $769K. The position accounts for 0.17% of the portfolio, ranked #116.

GSB Wealth Management first reported a position in MRNA in Q2 2021 and has held it in 12 quarters since. 722 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

  • GSB Wealth Management held 15,140 shares of Moderna worth $769K as of Q1 2026.
  • GSB Wealth Management bought 15 Moderna shares in Q1 2026, an estimated $700.
  • Moderna made up 0.17% of GSB Wealth Management's portfolio in Q1 2026, its #116 holding.
  • GSB Wealth Management first reported a position in Moderna in Q2 2021 and has held it in 12 quarters since.
  • 722 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on GSB Wealth Management's 13F filing for Q1 2026, filed 21 Apr 2026.